Elevation Wealth Partners’s Bio-Techne TECH Stock Holding History

Elevation Wealth Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.16K	Buy	73 +29	+66%	+$1.57K	﹤0.01%	1009
2026 Q1	$2.3K	Buy	44 +9	+26%	+$540	﹤0.01%	880
2025 Q4	$2.06K	Sell	35 -20	-36%	-$1.22K	﹤0.01%	787
2025 Q3	$3.06K	Sell	55 -745	-93%	-$39.9K	﹤0.01%	564
2025 Q2	$41.2K	Hold	800	–	–	0.02%	255
2025 Q1	$46.9K	Hold	800	–	–	0.02%	232
2024 Q4	$57.6K	Hold	800	–	–	0.02%	214
2024 Q3	$63.9K	Hold	800	–	–	0.03%	199
2024 Q2	$57.3K	Sell	800 -572	-42%	-$42.1K	0.03%	205
2024 Q1	$96.6K	Hold	1,372	–	–	0.05%	163
2023 Q4	$93.4K	Hold	1,372	–	–	0.06%	158
2023 Q3	$93.4K	Hold	1,372	–	–	0.08%	99
2023 Q2	$112K	Hold	1,372	–	–	0.09%	90
2023 Q1	$102K	Buy	+1,372	New	+$106K	0.09%	101

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Elevation Wealth Partners's TECH Position: Q2 2026 in Review

Elevation Wealth Partners increased its Bio-Techne (TECH) stake by 66% in Q2 2026, buying an estimated $1.57K and bringing the position to 73 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

Elevation Wealth Partners first reported a position in TECH in Q1 2023 and has held it in 14 quarters since. The position peaked at $112K in Q2 2023. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Elevation Wealth Partners held 73 shares of Bio-Techne worth $5.16K as of Q2 2026.
Elevation Wealth Partners bought 29 Bio-Techne shares in Q2 2026, an estimated $1.57K.
Bio-Techne made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1009 holding.
Elevation Wealth Partners first reported a position in Bio-Techne in Q1 2023 and has held it in 14 quarters since.
Elevation Wealth Partners's Bio-Techne position peaked at $112K in Q2 2023.
595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.